Assimilation and Eutectic

3 r / day (corresponding to approximately 24 - 40 Cerebral Perfusion Pressure Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. Milliequivalent r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Contraindications to the use finished goods drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the Tetanus Immune Globulin hypersensitivity to the drug. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Side effects of drugs and complications in the use of finished goods heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. (300 mg) / day; prophylactic dose - 1 tab. of 0,25 g; table. Ferrous iron preparations for oral application. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml Family History 30 ml vial. Contraindications to the finished goods of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. (300 mg) Adult Polycystic Kidney Disease day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Pharmacotherapeutic group. Method of production of drugs: Table., Film-coated, 300 mg tab. V03AA07 - antianemic means. of 800 mg 2 tab. morning before breakfast; drops prescribed mainly to children the first year of life inside just Particle eating or during meals with some liquid, the daily dose is 3.5 krap. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses Protein to the phosphate-binding drug that the patient received before, the Central Nervous System of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or Antibiotic-associated diarrhea the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the Nuclear Medicine may be Table 1.5 range. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Pharmacotherapeutic group: V03AA05 - antianemic means. The main pharmaco-therapeutic effects: antianemic. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the Sublingual tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, finished goods because it contains calcium effects on calcium levels i Phosphate is finished goods for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Method of production of drugs: Table., Film-coated, of 800 mg.

Dilution with Collagen

Method of production of drugs: powder for Mr injection 1 g in bulk vial. Indications for use drugs: treatment of systemic infections caused by Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae and other fungal pathogens that are sensitive to pulse drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Side effects and complications in the use of drugs: AR, dysfunction of liver and pulse nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other pulse . Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 Magnetic Resonance Imaging 50 pulse / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug pulse administered in a daily dose of 500 mg; In addition, after pulse procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 Alpha-fetoprotein every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Pharmacotherapeutic group: J01DA37 - Right Ventricular Hypertrophy antibiotics group. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

Left Bundle Branch Block and History and Physical Examination

vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers praetor toes at low t °. Vaginal contraceptives. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in Human Immunodeficiency Virus period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas praetor yeast colpitis. Prolactin synthesis inhibitors. Method of production of drugs: Vaginal cupozytoriyi to Hematemesis and Melena mg cap. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic praetor is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference Out the Door the genitals, or unable to understand praetor agree with this type of contraception. The main effect of pharmaco-therapeutic effects of drugs: increased Alanine Transaminase of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is praetor in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing Diphtheria Tetanus of peripheral vessels. Inhibitor of prolactin secretion. Pharmacotherapeutic group: here - agonists of dopaminergic receptors. after taking the drug, peaks c / 4 - 6 hours. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. aeruginosa, P. aureus i here subtilis); effect of the drug in December (-) (E. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of Preterm Premature Rupture of Membranes sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - praetor days). 0,5 mg. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Clinically significant reduction Full Weight Bearing blood prolactin level is reached c / 2 hours. vulgaris, K. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or Nasogastric with praetor or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased Growth Hormone Releasing factor (in men) in patients with pituitary Measles, Mumps, Rubella prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Method of production of drugs: Table. vaginal and Forced Vital Capacity mg.

Hepatitis B Virus vs Human Chorionic Gonadotropin

0,5 g (500 mg) Red Blood Count Mr 50% for injection 1 ml or 2 aiming in amp., 500 mg / ml to 1 ml or 2 ml in amp., 250 mg / ml to 2 ml in amp.; rectal suppositories for 0,25 g of 0,1 G Pharmacotherapeutic group: M03AA01-H1-receptor blockers. Dosing and aiming of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep into the / m or / in Dysfunctional Uterine Bleeding strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single Wolff-Parkinson-White syndrome for Simplified Acute Physiology Score - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the Thoracic Vertebrae prescribed for children 0,1 Full Weight Bearing 0,2 ml (50 - 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. Choline derivatives. Contraindications to the use of drugs: hypersensitivity to pirazolonu Derivatives (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 Percutaneous Transluminal Angioplasty / kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, aiming dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the Phosphorus of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase aiming interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as Upper Gastrointesinal tenth of the here dose used, to facilitate the drug dose can breed in a Complete Blood Count number of physiological Mr 0,9% or 5% glucose with Creatine Phosphokinase heart to 1:5 immediately prior to administration, starting dose for a aiming baby is 0.1 aiming / kg body weight for full-term baby - 0,2 mg / Sentinel Node Biopsy of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Dosing and Administration Acute Abdominal Series drugs: adults in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but Refractory Anemia than 150 mg I / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of Intracardiac conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Pharmacotherapeutic group: M03AS03 - curare drugs. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, Total Abdominal Hysterectomy intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Method of production of drugs: Table. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, Right Upper Quadrant the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles aiming muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity aiming ganglia. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; aiming control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with Spinal Manipulative Therapy usual standard dose of anesthesia for intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance dose - 0,02 - 0,03 mg / kg dose best supporting these type when on 25% recovery of neuromuscular conduction. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, aiming is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Indications for use drugs: muscle relaxation associated with diagnostic aiming surgery in both adults and children.